Machine Learning Identifies Stemness Features Associated with Oncogenic Dedifferentiation.
暂无分享,去创建一个
Joshua M. Stuart | A. Krasnitz | J. Weinstein | P. Laird | K. Hoadley | A. Gentles | H. Noushmehr | O. Gevaert | L. Omberg | H. Heyn | Patrycja Czerwińska | M. Wiznerowicz | A. Godwin | Artem Sokolov | A. Lazar | A. Colaprico | T. Malta | L. Poisson | L. Mishra | B. Kamińska | T. Burzykowski | J. Huelsken | Sylwia Mazurek
[1] Jonghwan Kim,et al. Embryonic stem cell-specific signatures in cancer: insights into genomic regulatory networks and implications for medicine , 2011, Genome Medicine.
[2] Adrian V. Lee,et al. Epigenomic Deconvolution of Breast Tumors Reveals Metabolic Coupling between Constituent Cell Types. , 2016, Cell reports.
[3] Ash A. Alizadeh,et al. Abstract PR09: The prognostic landscape of genes and infiltrating immune cells across human cancers , 2015 .
[4] Stuart H. Orkin,et al. A Myc Network Accounts for Similarities between Embryonic Stem and Cancer Cell Transcription Programs , 2010, Cell.
[5] Robert J. Lonigro,et al. Integrative Clinical Genomics of Metastatic Cancer , 2017, Nature.
[6] F. Schmitt,et al. Prognostic value of stromal tumour infiltrating lymphocytes and programmed cell death-ligand 1 expression in breast cancer , 2017, Journal of Clinical Pathology.
[7] Dan Roth,et al. Generalization Bounds for the Area Under the ROC Curve , 2005, J. Mach. Learn. Res..
[8] Daniel V. Oliveira,et al. StemChecker: a web-based tool to discover and explore stemness signatures in gene sets , 2015, Nucleic Acids Res..
[9] Benjamin J. Raphael,et al. Multiplatform Analysis of 12 Cancer Types Reveals Molecular Classification within and across Tissues of Origin , 2014, Cell.
[10] A. Regev,et al. An embryonic stem cell–like gene expression signature in poorly differentiated aggressive human tumors , 2008, Nature Genetics.
[11] C. Chai,et al. Overexpression of annexin 1 in the development and differentiation of urothelial carcinoma , 2012, The Kaohsiung journal of medical sciences.
[12] S. Tsai,et al. The miR‐200b–ZEB1 circuit regulates diverse stemness of human hepatocellular carcinoma , 2017, Molecular carcinogenesis.
[13] Gianluca Bontempi,et al. Moonlight: a tool for biological interpretation and driver genes discovery , 2018, bioRxiv.
[14] J. Ko,et al. Suberoylanilide hydroxamic acid (SAHA) causes tumor growth slowdown and triggers autophagy in glioblastoma stem cells , 2013, Autophagy.
[15] Claude Preudhomme,et al. A 17-gene stemness score for rapid determination of risk in acute leukaemia , 2016, Nature.
[16] Mariella G. Filbin,et al. Single-cell RNA-seq supports a developmental hierarchy in human oligodendroglioma , 2016, Nature.
[17] D. Friedmann-Morvinski,et al. Dedifferentiation and reprogramming: origins of cancer stem cells , 2014, EMBO reports.
[18] Mark M. Davis,et al. Autologous iPSC-Based Vaccines Elicit Anti-tumor Responses In Vivo. , 2018, Cell stem cell.
[19] Paul A Clemons,et al. The Connectivity Map: Using Gene-Expression Signatures to Connect Small Molecules, Genes, and Disease , 2006, Science.
[20] P. Royston,et al. Regression using fractional polynomials of continuous covariates: parsimonious parametric modelling. , 1994 .
[21] S. Leng,et al. EMT and stem cell-like properties associated with miR-205 and miR-200 epigenetic silencing are early manifestations during carcinogen-induced transformation of human lung epithelial cells. , 2011, Cancer research.
[22] J. Uhm. IDH1 mutation is sufficient to establish the glioma hypermethylator phenotype , 2012 .
[23] Gianluca Bontempi,et al. TCGAbiolinks: an R/Bioconductor package for integrative analysis of TCGA data , 2015, Nucleic acids research.
[24] Angela N. Brooks,et al. A Next Generation Connectivity Map: L1000 Platform and the First 1,000,000 Profiles , 2017, Cell.
[25] Sean C. Bendall,et al. Systemic Immunity Is Required for Effective Cancer Immunotherapy , 2017, Cell.
[26] R. Weinberg,et al. EMT, CSCs, and drug resistance: the mechanistic link and clinical implications , 2017, Nature Reviews Clinical Oncology.
[27] Hong-Yang Wang,et al. Acetyl‐coenzyme A carboxylase alpha promotion of glucose‐mediated fatty acid synthesis enhances survival of hepatocellular carcinoma in mice and patients , 2016, Hepatology.
[28] Adam A. Margolin,et al. Integrated Genomic Analysis of Diverse Induced Pluripotent Stem Cells from the Progenitor Cell Biology Consortium , 2016, Stem cell reports.
[29] R. Wilson,et al. Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma. , 2010, Cancer cell.
[30] J. Gingold,et al. Modeling Cancer with Pluripotent Stem Cells. , 2016, Trends in cancer.
[31] Angelo J. Canty,et al. Stem cell gene expression programs influence clinical outcome in human leukemia , 2011, Nature Medicine.
[32] R Core Team,et al. R: A language and environment for statistical computing. , 2014 .
[33] T. Graeber,et al. Mutations Associated with Acquired Resistance to PD-1 Blockade in Melanoma. , 2016, The New England journal of medicine.
[34] Richard A Young,et al. Control of the Embryonic Stem Cell State , 2011, Cell.
[35] D. Hanahan,et al. Hallmarks of Cancer: The Next Generation , 2011, Cell.
[36] C-Y Lin,et al. Identification of thioridazine, an antipsychotic drug, as an antiglioblastoma and anticancer stem cell agent using public gene expression data , 2015, Cell Death and Disease.
[37] B. Bao,et al. Over‐expression of FoxM1 leads to epithelial–mesenchymal transition and cancer stem cell phenotype in pancreatic cancer cells , 2011, Journal of cellular biochemistry.
[38] A. Brivanlou,et al. Molecular signature of human embryonic stem cells and its comparison with the mouse. , 2003, Developmental biology.
[39] S. Plevritis,et al. Identification of ovarian cancer driver genes by using module network integration of multi-omics data , 2013, Interface Focus.
[40] Jeong Eon Lee,et al. Single-cell RNA-seq enables comprehensive tumour and immune cell profiling in primary breast cancer , 2017, Nature Communications.
[41] Dylan M. Marchione,et al. Impaired H3K36 methylation defines a subset of head and neck squamous cell carcinomas , 2017, Nature Genetics.
[42] Julie V. Harness,et al. Recurrent variations in DNA methylation in human pluripotent stem cells and their differentiated derivatives. , 2012, Cell stem cell.
[43] Benjamin J Raphael,et al. Comprehensive Pan-Genomic Characterization of Adrenocortical Carcinoma. , 2016, Cancer cell.
[44] Alexander R. Pico,et al. Molecular, phenotypic, and sample-associated data to describe pluripotent stem cell lines and derivatives , 2017, Scientific Data.
[45] Lijing Yao,et al. Inferring regulatory element landscapes and transcription factor networks from cancer methylomes , 2015, Genome Biology.
[46] D. Medici,et al. Signaling mechanisms of the epithelial-mesenchymal transition , 2014, Science Signaling.
[47] P. Grambsch,et al. Estimating the Survival and Hazard Functions , 2000 .
[48] J. Visvader,et al. Cancer stem cells: current status and evolving complexities. , 2012, Cell stem cell.
[49] Gary D Bader,et al. Inhibition of Dopamine Receptor D4 Impedes Autophagic Flux, Proliferation, and Survival of Glioblastoma Stem Cells. , 2016, Cancer cell.
[50] Radu Dobrin,et al. Dissecting self-renewal in stem cells with RNA interference , 2006, Nature.
[51] R. Ferris,et al. Immunotherapy for Head and Neck Squamous Cell Carcinoma , 2018, Current Oncology Reports.
[52] F. Bertucci,et al. PDL1 expression is an independent prognostic factor in localized GIST , 2015, Oncoimmunology.
[53] I. Ng,et al. MiR-200b/200c/429 subfamily negatively regulates Rho/ROCK signaling pathway to suppress hepatocellular carcinoma metastasis , 2015, Oncotarget.
[54] Michele Ceccarelli,et al. TCGAbiolinksGUI: A graphical user interface to analyze GDC cancer molecular and clinical data , 2017, bioRxiv.
[55] A. Psyrri,et al. The emerging role of immunotherapy in head and neck squamous cell carcinoma (HNSCC): anti-tumor immunity and clinical applications. , 2016, Annals of translational medicine.
[56] G. Goodall,et al. The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1 , 2008, Nature Cell Biology.
[57] Pablo Tamayo,et al. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[58] Olivier Elemento,et al. Stem Cell Lineage Infidelity Drives Wound Repair and Cancer , 2017, Cell.
[59] K. Tomczak,et al. The Cancer Genome Atlas (TCGA): an immeasurable source of knowledge , 2015, Contemporary oncology.
[60] E. Hurt,et al. Gossypol Induces Apoptosis by Activating p53 in Prostate Cancer Cells and Prostate Tumor–Initiating Cells , 2010, Molecular Cancer Therapeutics.
[61] Jaime Rodriguez-Canales,et al. A Patient-Derived, Pan-Cancer EMT Signature Identifies Global Molecular Alterations and Immune Target Enrichment Following Epithelial-to-Mesenchymal Transition , 2015, Clinical Cancer Research.
[62] Fang Liu,et al. Overexpression of annexin 1 in pancreatic cancer and its clinical significance. , 2004, World journal of gastroenterology.
[63] A. Kimmelman,et al. Metabolic Interactions in the Tumor Microenvironment. , 2017, Trends in cell biology.
[64] Yan Shi,et al. Roles of dopamine receptors and their antagonist thioridazine in hepatoma metastasis , 2015, OncoTargets and Therapy.
[65] R. Young,et al. Transcriptional Addiction in Cancer , 2017, Cell.
[66] Alexey Sergushichev,et al. An algorithm for fast preranked gene set enrichment analysis using cumulative statistic calculation , 2016 .
[67] T. Mikkelsen,et al. A Distinct DNA Methylation Shift in a Subset of Glioma CpG Island Methylator Phenotypes during Tumor Recurrence , 2018, Cell reports.
[68] D. Gifford,et al. Analysis of the mouse embryonic stem cell regulatory networks obtained by ChIP-chip and ChIP-PET , 2008, Genome Biology.
[69] I. Mellman,et al. Oncology meets immunology: the cancer-immunity cycle. , 2013, Immunity.
[70] Steven J. M. Jones,et al. Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma , 2016, Cell.
[71] Bonnie Berger,et al. A gene expression profile of stem cell pluripotentiality and differentiation is conserved across diverse solid and hematopoietic cancers , 2012, Genome Biology.
[72] A. Viale,et al. Remodeling of the Methylation Landscape in Breast Cancer Metastasis , 2014, PloS one.
[73] David T. W. Jones,et al. Hotspot mutations in H3F3A and IDH1 define distinct epigenetic and biological subgroups of glioblastoma. , 2012, Cancer cell.
[74] Nathan D Price,et al. A CD133-related gene expression signature identifies an aggressive glioblastoma subtype with excessive mutations , 2011, Proceedings of the National Academy of Sciences.
[75] Yi Wang,et al. Overexpression of FOXM1 predicts poor prognosis and promotes cancer cell proliferation, migration and invasion in epithelial ovarian cancer , 2014, Journal of Translational Medicine.
[76] C. Shaw,et al. Molecular Signatures of Proliferation and Quiescence in Hematopoietic Stem Cells , 2004, PLoS biology.
[77] Liang Xu,et al. WNT pathway inhibitor pyrvinium pamoate inhibits the self-renewal and metastasis of breast cancer stem cells. , 2016, International journal of oncology.
[78] Ash A. Alizadeh,et al. Association of a leukemic stem cell gene expression signature with clinical outcomes in acute myeloid leukemia. , 2010, JAMA.
[79] Min Liu,et al. Overexpression of FoxM1 is associated with tumor progression in patients with clear cell renal cell carcinoma , 2012, Journal of Translational Medicine.
[80] L. Qin,et al. Targeting Lung Cancer Stem Cells with Antipsychological Drug Thioridazine , 2016, BioMed research international.
[81] S. Berger,et al. IDH mutation impairs histone demethylation and results in a block to cell differentiation , 2012, Nature.
[82] I. Fabregat,et al. New Insights into the Crossroads between EMT and Stemness in the Context of Cancer , 2016, Journal of clinical medicine.
[83] Y. Benjamini,et al. Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .
[84] Artem Sokolov,et al. One-Class Detection of Cell States in Tumor Subtypes , 2016, PSB.
[85] Michael Q. Zhang,et al. Integrative analysis of 111 reference human epigenomes , 2015, Nature.